The Bright Side of the Road: FDA Decision on MDMA Leaves Psychedelic Therapy Down, Far From Out (JSON)

lexblog.com/lib/TSVT14Q6view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The Bright Side of the Road: FDA Decision on MDMA Leaves Psychedelic Therapy Down, Far From Out",
    "url": "https://www.lexblog.com/2024/08/26/the-bright-side-of-the-road-fda-decision-on-mdma-leaves-psychedelic-therapy-down-far-from-out/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-TSVT14Q6",
        "url": "https://www.lexblog.com/lib/TSVT14Q6/"
    },
    "datePublished": "2024-08-26T10:29:48-04:00",
    "dateModified": "2024-08-26T11:08:41-04:00",
    "author": {
        "@type": "Person",
        "name": "Hillary Campbell, Whitt Steineker"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Bradley Arant Boult Cummings LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Budding Trends",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.buddingtrendsblog.com/?p=3054",
    "sourceStability": "may-move"
}